Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-09-24FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original application for clobetasol propionate topical (generic) by Zydus Lifesciences Limited, adding another generic opti…
-
FDA approval · 2019-09-17FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc., resulting in changes to the approved product, such as labeling …
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) [Phase 3]
Phase 3 trial update evaluating the safety and efficacy of FURESTEM-AD Inj. in adults with moderate to severe chronic atopic dermatitis has …
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE EMOLLIENT FORMULATION — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for a clobetasol propionate emollient formulation from Padagis Israel Pharmaceuticals Ltd, granting …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries, enhancing its approval under the gener…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: A Trial of Antroquinonol in Patients With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial assessing Antroquinonol in patients with Atopic Dermatitis has completed.
-
FDA approval · 2019-08-29FDA Approved: PIMECROLIMUS — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for PIMECROLIMUS from Glenmark Pharmaceuticals Inc., USA for topical use in atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children? [Phase 4]
A Phase 4 trial evaluated whether montelukast improves symptoms of atopic dermatitis in children.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis [Phase 2]
Phase 2 trial update for Crisaborole ointment 2% in atopic dermatitis with biomarker biopsy results completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Role of Anti-IgE in Severe Childhood Eczema [Phase 4]
Phase 4 trial evaluating anti-IgE therapy for severe childhood eczema has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin) [Phase 3]
Phase 3 trial investigating 0.1% tacrolimus ointment for moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating generic pimecrolimus 1% cream for mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase II study of bermekimab (MABp1) in moderate to severe atopic dermatitis has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting efficacy and safety of dupilumab in participants aged 12 to under 18 with moderate-to-severe atopic dermatiti…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Secukinumab for Treatment of Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating secukinumab for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis [Phase 2]
Phase 2 trial of a botanical drug containing East Indian Sandalwood Oil for atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis [Phase 2]
Phase 2 randomized placebo-controlled trial assessing safety, pharmacodynamics, and efficacy of ILV-094 in atopic dermatitis completed with …
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants [NA]
A completed clinical trial comparing Cetaphil Restoraderm system to standard skin care in infants with atopic dermatitis; results posted in …
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis [Phase 1, Phase 2]
A combined Phase 1/2 clinical trial evaluated the safety and efficacy of ZPL-5212372 in healthy subjects and in patients with atopic dermati…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis [Phase 2]
Phase 2 trial assessing serlopitant for pruritus in adults with atopic dermatitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis [Phase 1]
Phase 1 study evaluating crisaborole ointment 2% in healthy adult Japanese subjects and adults with mild to moderate atopic dermatitis; stud…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]
An ascending multiple-dose study of the investigational drug VTP-38543 in adults with mild-to-moderate atopic dermatitis (Phase 1/2) has com…
-
FDA approval · 2019-02-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's generic clobetasol propionate topical product under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Potential Research Study Participant Registry
This update notes the completion of a University of California, Davis-sponsored clinical trial participant registry focused on several skin …